Advance Search
ZHOU Zijiao, WANG Ruigang, ZHANG Yan, DONG Feifei, WU Hua, LIU Huafeng. Effect of Sangxia Lingzhu Decoction in treating patients with stroke associated pneumonia[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 62-65. DOI: 10.7619/jcmp.20202001
Citation: ZHOU Zijiao, WANG Ruigang, ZHANG Yan, DONG Feifei, WU Hua, LIU Huafeng. Effect of Sangxia Lingzhu Decoction in treating patients with stroke associated pneumonia[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 62-65. DOI: 10.7619/jcmp.20202001
shu

Effect of Sangxia Lingzhu Decoction in treating patients with stroke associated pneumonia

  • 1.

    Fengnan District Traditional Chinese Medicinal Hospital in Tangshan City of Hebei Province, Tangshan, Hebei, 063210

  • 2.

    Affiliated Hospital of North China University of Technology, Tangshan, Hebei, 063000

More Information
  • Received Date: December 14, 2020
  • Available Online: January 17, 2021
  • Published Date: January 14, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To investigate effect of Sangxia Lingzhu Decoction on serum inflammatory factors and peripheral blood lymphocyte subsets in patients with stroke associated pneumonia (SAP).
      Methods  A total of 110 patients with SAP were selected, and were divided into two groups by random number table method. A total of 55 patients receiving routine treatment were selected as control group, and the rest of 55 patients given Sangxia Lingzhu Decoction based on the control group were selected as observation group. Levels of serum inflammatory factors and peripheral blood lymphocyte subsets were detected before and after treatment. Disease improvement conditions and clinical effects of two groups were compared between two groups.
      Results  The levels of C-reactive protein, interleukin (IL)-1β, IL-4, IL-6 and TNF-α in the two groups after treatment were significantly lower than those before treatment, and the levels of CD3+, CD4+, CD8+ and CD4+/CD8+ in two groups after treatment were significantly higher than those before treatment(P < 0.05). After treatment, the levels of C-reactive protein, IL-1β, IL-4, IL-6 and TNF-α in the observation group were significantly lower, the levels of CD3+, CD4+, CD8+ and CD4+/CD8+ in the observation group were significantly higher, and disappearance time of cough, fever, lung dampness rale as well as suffocation in the observation group was significantly shorter than that in the control group (P < 0.05). Total effective rate in observation group was significantly higher than that in the control group (P < 0.05).
      Conclusion  Sangxia Lingzhu Decoction can relieve inflammatory reactions in patients with stroke associated pneumonia, regulate the levels of peripheral blood lymphocyte subsets, shorten disease improvement time and improve clinical effect.
    • FullText(HTML)
    • References (20)
  • [1]
    FINLAYSON O, KAPRAL M, HALL R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke[J]. Neurology, 2011, 77(14): 1338-1345. doi: 10.1212/WNL.0b013e31823152b1
    [2]
    单凯, 郭伟. 卒中相关性肺炎诊疗进展[J]. 中国卒中杂志, 2016, 11(4): 324-330. doi: 10.3969/j.issn.1673-5765.2016.04.016
    [3]
    赵东亚, 孟晨, 施敏. 抗感染基础上联合乌司他丁对重症肺炎临床效果及炎性因子、T淋巴细胞亚群的影响[J]. 临床医药文献电子杂志, 2019, 6(79): 39-39. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201979030.htm
    [4]
    刘秋红, 张杰文, 杨景瑞. 老年卒中相关性肺炎患者外周血T淋巴细胞亚群及血清炎症因子变化的临床分析[J]. 中国实用神经疾病杂志, 2016, 19(8): 34-35. doi: 10.3969/j.issn.1673-5110.2016.08.018
    [5]
    侯晓夏, 徐勤荣, 桂千, 等. T淋巴细胞亚群和NK细胞在脑卒中相关性肺炎患者中的变化及临床意义[J]. 中国老年学杂志, 2019, 39(16): 3963-3965. doi: 10.3969/j.issn.1005-9202.2019.16.031
    [6]
    中国卒中学会急救医学分会, 中华医学会急诊医学分会卒中学组, 中国老年医学学会急诊医学分会, 等. 卒中相关性肺炎诊治中国专家共识(2019更新版)[J]. 中华急诊医学杂志, 2019, 28(12): 1476-1484. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUZH201912014.htm
    [7]
    中华医学会神经病学分会脑血管病学组急性缺血性脑卒中. 中国急性缺血性脑卒中诊治指南2010[J]. 中国全科医学, 2011, 14(35): 4013-4017. doi: 10.3969/j.issn.1007-9572.2011.35.004
    [8]
    张丽芳, 冯志兰, 赵艳红, 等. 健脾清肺通络汤联合依达拉奉治疗急性卒中后肺炎临床研究[J]. 现代中西医结合杂志, 2019, 28(23): 3719-3722. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH201933019.htm
    [9]
    孙文霞, 吴刚. 老年脑卒中患者并发医院获得性肺炎的危险因素分析[J]. 新疆医科大学学报, 2019, 42(11): 1459-1463. doi: 10.3969/j.issn.1009-5551.2019.11.017
    [10]
    温德良, 李智博, 温艺超, 等. 重症监护病房脑卒中相关性肺炎多重耐药菌感染的危险因素及病原学分析[J]. 实用医学杂志, 2016, 32(13): 2178-2181. doi: 10.3969/j.issn.1006-5725.2016.13.029
    [11]
    林萍, 付金霞, 张贺男, 等. 脑卒中并发肺炎患者病原菌、危险因素及T淋巴细胞水平分析[J]. 中国病原生物学杂志, 2019, 14(7): 826-829. https://www.cnki.com.cn/Article/CJFDTOTAL-ZISC201907018.htm
    [12]
    费雪洁, 熊旭东, 李淑芳, 等. 社区获得性肺炎诊疗新进展[J]. 河北医药, 2015, 37(3): 418-420. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201503039.htm
    [13]
    张溪, 刘娜, 云芯芯, 等. 中医经方验方治疗卒中相关性肺炎随机对照试验系统评价[J]. 新中医, 2019, 51(2): 50-53. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201902012.htm
    [14]
    宋苹, 张溪, 姚怀国. 卒中相关性肺炎的中医症状及证型特征[J]. 实用医学杂志, 2018, 34(9): 162-165. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201809041.htm
    [15]
    HUNTER C A, JONES S A. IL-6 as a keystone cytokine in health and disease[J]. Nat Immunol, 2015, 16(5): 448-457. doi: 10.1038/ni.3153
    [16]
    SNAUWAERT S, VERSTICHEL G, BONTE S, et al. In vitro generation of mature, native antigen-specific CD8+ T cells with a single T-cell receptor by agonist selection[J]. Leukemia, 2014, 28(4): 830-841. doi: 10.1038/leu.2013.285
    [17]
    徐彦忠. 参苓白术散加减治疗老年社区获得性肺炎45例临床分析[J]. 黑龙江中医药, 2018, 48(4): 50-51. https://www.cnki.com.cn/Article/CJFDTOTAL-HLZY201804027.htm
    [18]
    叶艳阳, 宣志红, 骆仙芳. 参苓白术散加减预防呼吸机相关性肺炎35例临床观察[J]. 浙江中医杂志, 2019, 54(5): 328-331. doi: 10.3969/j.issn.0411-8421.2019.05.012
    [19]
    王雪梅. 桑白皮汤加减治疗慢阻肺急性加重期痰热郁肺的研究[J]. 中西医结合心血管病电子杂志, 2019, 7(35): 156-156. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXJH201935127.htm
    [20]
    张宝凤. 桑白皮汤加减治疗小儿类百日咳综合征60例临床观察[J]. 当代医学, 2018, 24(20): 32-34. doi: 10.3969/j.issn.1009-4393.2018.20.013
    • Related Articles

  • Related Articles

    [1]MENG Lijun, ZHANG Lanfang, QIN Lei, LI Wenjing, SHEN Peijun, CHEN Xu, GUO Xiaohe. Values of serum tumor necrosis factor-α stimulated gene 6 protein and type ⅩⅥ collagen in predicting prognosis of patients with ulcerative colitis[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 87-90, 95. DOI: 10.7619/jcmp.20243615
    [2]ZHANG Xiaohui. Efficacy of mesalazine alone and live bifidobacterium in combination on the treatment of ulcerative colitis and their effects on TNF-α, IL-6 and IL-8 levels[J]. Journal of Clinical Medicine in Practice, 2018, (3): 112-114. DOI: 10.7619/jcmp.201803032
    [3]WEI Xuefei, XU Pei, CHEN Zairong, GUO Wanhua. Expressions and significance of serum IFN-γ,IL-4, IL-6 and IL-10 in treatment of patients with renal cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (7): 68-70. DOI: 10.7619/jcmp.201507019
    [4]ZHANG Hu, LI Zhi. Effect of Astragalus injection on serum tumor necrosis factor-α, interleukin-6 and angiotensin Ⅱ in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (23): 17-19. DOI: 10.7619/jcmp.201423006
    [5]ZHANG Mingsen, WANG Bin, SUN Yang. Effects of different intravascular volume expansion solutions on serum levels of TNF-α and IL-6 in perioperative patients with craniocerebral trauma[J]. Journal of Clinical Medicine in Practice, 2014, (21): 52-54. DOI: 10.7619/jcmp.201421015
    [6]QIU Zhenqin, DU Zhongde, XU Jiagang. Influence of Danhong injection on the level of serum interleukin-6 and Interleukin-10 in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (19): 17-19. DOI: 10.7619/jcmp.201419006
    [7]BAI Yun, QIU Chuxiong, XUE Weixin, LIN Feng, HUANG Shouyuan, NING Liangzhong, ZHANG Chenghao, YAO Yongzhi. Clinical efficacy of Shenkang Injection and its influence on C-reactive protein and interleukin-6 levels in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2014, (15): 17-19. DOI: 10.7619/jcmp.201415006
    [8]WU Yiping. Clinical significance of serum tumor necrosis factor-α and interleukin-6 in measuring acute intussusception in the infants[J]. Journal of Clinical Medicine in Practice, 2013, (24): 75-77. DOI: 10.7619/jcmp.201324022
    [9]MO Liya, WU Yonghua, WANG Minhong. Association of IL-6, TNF-α and clinical stages,ventilation function in elderly patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (19): 4-6. DOI: 10.7619/jcmp.201319002
    [10]SUN Changjiang, FAN Hui, GE Jianbin. Effect of Xuebijing injection on serum concentrations of TNF-α, IL-1β and IL-6in patients with acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2013, (9): 83-85,90. DOI: 10.7619/jcmp.201309029

  • Cited by

    Periodical cited type(15)

    1. 马治娥，赵文娟，王沛. 不同质子泵抑制剂对胃溃疡患者胃肠激素及氧化应激的影响. 贵州医药. 2024(01): 55-56 .
    2. 孙敏. 四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌感染患者的临床效果分析. 中国校医. 2024(01): 61-64 .
    3. 黄莉莉，黄晶晶. 奥美拉唑联合纤维蛋白粘合剂在消化性溃疡出血中的应用效果分析. 中国烧伤创疡杂志. 2024(03): 240-244 .
    4. 王燕，宋建国，李红，温爽，付琳璐. 雷尼替丁联合消化内镜对十二指肠溃疡的治疗效果. 中国医药指南. 2024(16): 86-89 .
    5. 刘雅红. 单用质子泵抑制剂治疗消化性溃疡对根除幽门螺杆菌的影响. 中国现代药物应用. 2024(14): 112-114 .
    6. 白玲，赵琴. 血清谷胱甘肽过氧化物酶、脂质过氧化物水平与妊娠期糖尿病及其糖脂代谢异常、胰岛素抵抗和母婴结局的关系. 安徽医药. 2024(11): 2226-2230 .
    7. 陈偲. 小组式知信行健康宣教在消化道溃疡患者中的应用. 江苏卫生事业管理. 2024(10): 1420-1422 .
    8. 王建东. 愈疡健脾方联合质子泵抑制剂治疗脾胃虚寒型消化性溃疡的临床观察. 基层医学论坛. 2024(36): 153-156 .
    9. 陈波，张庆团，黄克锋，杨燕芬，熊弋平. 瑞巴派特四联疗法对幽门螺杆菌阳性消化性溃疡患者血清氧化应激指标和胃蛋白酶原的影响. 现代生物医学进展. 2023(11): 2168-2172 .
    10. 黄小花. 健胃愈疡汤辅助四联疗法治疗十二指肠溃疡的效果及对溃疡面积、胃肠相关指标的影响. 临床合理用药. 2023(29): 81-84 .
    11. 俞洪韵，陈慧丽，朱锋，汪璇，陶治华. 健胃愈疡颗粒联合西咪替丁治疗重症患者应激性溃疡的临床研究. 现代药物与临床. 2023(10): 2506-2510 .
    12. 胡量. 康复新液治疗胃溃疡的临床疗效及对炎性因子、氧化应激和胃黏膜修复作用的影响分析. 现代诊断与治疗. 2023(17): 2543-2545+2556 .
    13. 陆文鹏，陈民，陈洁，郑新梅，董小耘. 基于生物信息学探讨败酱散调控氧化应激缓解克罗恩病的机制. 实用临床医药杂志. 2022(16): 11-17 . 本站查看
    14. 黄以治. 胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果. 中国医药指南. 2022(35): 29-32 .
    15. 张珊珊，刘畅，阴雨龙. 奥美拉唑与雷尼替丁治疗十二指肠溃疡的疗效对比分析. 中外医疗. 2022(31): 136-139 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (392) PDF downloads (11) Cited by(18)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return